VERTEX PHARMACEUTICALS INC / MA Depreciation
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Depreciation of $155.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-02-13
- VERTEX PHARMACEUTICALS INC / MA depreciation for fiscal 2025 was $155.80M, a 2.87% decline from fiscal 2024.
- VERTEX PHARMACEUTICALS INC / MA depreciation for fiscal 2024 was $160.40M, a 4.41% decline from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA depreciation for fiscal 2023 was $167.80M, a 13.15% increase from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA depreciation for fiscal 2022 was $148.30M, a 18.07% increase from fiscal 2021.
| Period end | Depreciation 12 month |
|---|---|
| 2025-12-31 | $155.80M 10-K · filed 2026-02-13 |
| 2024-12-31 | $160.40M 10-K · filed 2026-02-13 |
| 2023-12-31 | $167.80M 10-K · filed 2026-02-13 |
| 2022-12-31 | $148.30M 10-K · filed 2025-02-13 |
| 2021-12-31 | $125.60M 10-K · filed 2024-02-15 |
| 2020-12-31 | $109.50M 10-K · filed 2023-02-10 |
| 2019-12-31 | $106.90M 10-K · filed 2022-02-09 |
| 2018-12-31 | $72.40M 10-K · filed 2021-02-11 |
| 2017-12-31 | $61.40M 10-K · filed 2020-02-13 |
| 2016-12-31 | $60.80M 10-K · filed 2019-02-13 |
| 2015-12-31 | $60.00M 10-K · filed 2018-02-15 |
| 2014-12-31 | $62.30M 10-K · filed 2017-02-23 |
| 2013-12-31 | $47.30M 10-K · filed 2016-02-16 |
| 2012-12-31 | $35.70M 10-K · filed 2015-02-13 |
| 2011-12-31 | $28.90M 10-K · filed 2014-02-11 |
| 2010-12-31 | $27.90M 10-K · filed 2013-03-01 |
| 2009-12-31 | $28.30M 10-K · filed 2012-02-22 |
| 2008-12-31 | $30.40M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |